Nonpharmacological interventions for 'no-option' refractory angina patients
- PMID: 37942734
- DOI: 10.2459/JCM.0000000000001566
Nonpharmacological interventions for 'no-option' refractory angina patients
Abstract
Refractory angina pectoris (RAP) defined as chronic anginal chest pain because of coronary artery disease (CAD) is a major problem. The increase in the number of patients with RAP in recent years is because of the increasing aging population and improved survival rates among patients with CAD. Management of patients with RAP is often extremely challenging. In this review, we present several interventional approaches for RAP, including device therapies, lifestyle intervention, and cell therapies. Some of these treatments are currently used in the management of RAP, whereas other treatments are under investigation.
Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.
References
-
- Makowski M, Makowska JS, Zielińska M. Refractory angina-unsolved problem. Cardiology clinics 2020; 38:629–637.
-
- Henry TD, Satran D, Hodges JS, et al. Long-term survival in patients with refractory angina. Eur Heart J 2013; 34:2683–2688.
-
- Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina: report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23:355–370.
-
- McGillion M, Arthur HM, Cook A, et al. Canadian Cardiovascular Society, Canadian Pain Society. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can J Cardiol 2012; 28: (2 Suppl): S20–41.
-
- Andréll P, Ekre O, Grip L, et al. Fatality, morbidity and quality of life in patients with refractory angina pectoris. Int J Cardiol 2011; 147:377–382.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous